EpiVax, Inc.
- Biotech or pharma, therapeutic R&D
- Biotech or pharma, animal health
- CMO, CRO
- Other R&D services
- Other products or services
EpiVax is a leader in immunogenicity assessment and sequence optimization for biologic therapeutics and vaccines. Since 1998, we’ve provided biologic and vaccine developers with cutting-edge in silico and in vitro tools for assessing candidate immunogenicity at the preclinical stage. At BIO, we are focused on partnering in immunogenicity screening, vaccine design, and personalized cancer vaccines via our Ancer® platform. We also offer expertise in tolerance induction and immune modulation, supporting therapies for autoimmune diseases, allergy, and other immune-related conditions.
)
)
)
)
){kind=logo}
){kind=logo}
)
){kind=logo}
)
){kind=logo}
){kind=logo}